On November 12, 2024, from 12 to 1 PM ET, the Annual Life Sciences Litigation CLE Week unfolds with a focus on the 340B drug discount program. The session examines ongoing litigation and potential legal implications, while providing vital information for legal practitioners navigating a complex landscape. Attendees will benefit from CLE credits, enhancing their professional qualifications.
Join the enlightening journey through the evolving landscape of the 340B drug discount program during the Annual Life Sciences Litigation CLE Week. On November 12, 2024, from noon to 1 PM ET, this webinar will dive into recent legal challenges, including disputes over manufacturer contract pharmacy limits. Attendees will also explore the significant implications of the Loper Bright case and understand emerging mechanisms against duplicate 340B discounts, especially as influenced by the Inflation Reduction Act’s regulations. As part of a captivating six-part series, this event marks the beginning of a compelling discussion on critical legal topics. Subsequent sessions will address relevant interests, such as changes in Federal Rules of Evidence, insights on MDLs, and product liability trends across Europe and AI’s impact on liability law, ensuring participants are well-informed on contemporary legal issues. Each session is poised to earn attendees 1.0 CLE credit across several states, including California and New York. Those licensed in other jurisdictions will receive a uniform certificate of attendance, ensuring that their engagement is recognized. Reed Smith will collect CLE applications for several other states, paving the way for widespread professional growth and knowledge sharing among legal professionals.
The 340B drug discount program serves as a crucial resource for healthcare providers to access medications at reduced prices, especially for underserved populations. Recent legal challenges and legislative changes threaten its current framework, prompting an urgent discussion on the implications of these developments. Knowledge about ongoing litigation and state initiatives will be key for legal professionals navigating this complex arena.
The Annual Life Sciences Litigation CLE Week offers a vital opportunity to stay abreast of significant developments in the 340B program. Through engaging discussions and expert insights, attendees will gain a deeper understanding of current legal challenges and emerging trends. This series promises to enlighten legal practitioners and enhance their knowledge in applicable regulatory landscapes.
Original Source: www.reedsmith.com
